Kimelman & Baird’s Ambev ABEV Stock Holding History

Kimelman & Baird’s Portfolio ABEV Stock Details ABEV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-10,000	Closed	-$65K	–	117
2014 Q3	$65K	Hold	10,000	–	–	0.01%	110
2014 Q2	$70K	Buy	+10,000	New	+$73.6K	0.01%	111

Other funds holding ABEV

VAM

Vontobel Asset Management New York $18.1B AUM 28.09% 1-Year Est. Return

Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

MNA

Manning & Napier Advisors Fairport, New York $7.8B AUM 25.03% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GTP

Global Thematic Partners New York $120M AUM 25.18% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Kimelman & Baird's ABEV Position: Q4 2014 in Review

Kimelman & Baird sold out of Ambev (ABEV) in Q4 2014, closing a stake of 10,000 shares — an estimated $65K sold.

Kimelman & Baird first reported a position in ABEV in Q2 2014 and held it in 2 quarters. The position peaked at $70K in Q2 2014. 299 funds tracked by Wall St. Rank hold ABEV as of Q4 2014.

Kimelman & Baird reported no remaining Ambev position as of Q4 2014 after selling out during the quarter.
Kimelman & Baird sold 10,000 Ambev shares in Q4 2014, an estimated $65K.
Kimelman & Baird first reported a position in Ambev in Q2 2014 and held it in 2 quarters.
Kimelman & Baird's Ambev position peaked at $70K in Q2 2014.
299 funds tracked by Wall St. Rank held Ambev as of Q4 2014.

Based on Kimelman & Baird's 13F filing for Q4 2014, filed 12 Feb 2015.